Literature DB >> 1629744

Quantitative autoradiography of dihydrorotenone binding to complex I of the electron transport chain.

J T Greenamyre1, D S Higgins, R V Eller.   

Abstract

Defective complex I activity has been linked to Parkinson's disease and Huntington's disease, but little is known of the regional distribution of this enzyme in the brain. We have developed a quantitative autoradiographic assay using [3H]dihydrorotenone ([3H]DHR) to label and localize complex I in brain tissue sections. Binding was specific and saturable and in the cerebellar molecular layer had a KD of 11.5 +/- 1.3 nM and a Bmax of 11.0 +/- 0.4 nCi/mg of tissue. Unlabeled rotenone and 1-methyl-4-phenylpyridinium ion competed effectively for DHR binding sites. Binding was markedly enhanced by 100 microM NADH. The distribution of complex I in brain, as revealed by DHR autoradiography, is unique but somewhat similar to that of cytochrome oxidase (complex IV). This assay may provide new insight into the roles of complex I in brain function and neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629744     DOI: 10.1111/j.1471-4159.1992.tb09431.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  [3H]dihydrorotenone binding to NADH: ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study.

Authors:  D S Higgins; J T Greenamyre
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

2.  Mitochondrial avid radioprobes. Preparation and evaluation of 7'(Z)-[125I]iodorotenone and 7'(Z)-[125I]iodorotenol.

Authors:  Henry F VanBrocklin; Stephen M Hanrahan; Joel D Enas; Erathodiyil Nandanan; James P O'Neil
Journal:  Nucl Med Biol       Date:  2006-11-28       Impact factor: 2.408

3.  Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents.

Authors:  James G Greene; Raymond Dingledine; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2010-03-20       Impact factor: 5.996

Review 4.  Glutamate and Parkinson's disease.

Authors:  F Blandini; R H Porter; J T Greenamyre
Journal:  Mol Neurobiol       Date:  1996-02       Impact factor: 5.590

Review 5.  An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.

Authors:  Andrea Terron; Anna Bal-Price; Alicia Paini; Florianne Monnet-Tschudi; Susanne Hougaard Bennekou; Marcel Leist; Stefan Schildknecht
Journal:  Arch Toxicol       Date:  2017-12-05       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.